Complex movement disorders induced by fluoxetine
Identifieur interne :
003388 ( PascalFrancis/Corpus );
précédent :
003387;
suivant :
003389
Complex movement disorders induced by fluoxetine
Auteurs : K. J. Bharucha ;
K. D. SethiSource :
-
Movement disorders [ 0885-3185 ] ; 1996.
RBID : Pascal:96-0244904
Descripteurs français
- Pascal (Inist)
- Fluoxétine,
Antidépresseur,
Psychotrope,
Inhibiteur recapture,
Sérotonine,
Mouvement involontaire,
Traitement,
Chimiothérapie,
Toxicité,
Homme,
Etude cas.
English descriptors
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 11 |
|---|
| A06 | | | | @2 3 |
|---|
| A08 | 01 | 1 | ENG | @1 Complex movement disorders induced by fluoxetine |
|---|
| A11 | 01 | 1 | | @1 BHARUCHA (K. J.) |
|---|
| A11 | 02 | 1 | | @1 SETHI (K. D.) |
|---|
| A14 | 01 | | | @1 Department of Neurology, Medical College of Georgia @2 Augusta, Georgia @3 USA @Z 1 aut. @Z 2 aut. |
|---|
| A20 | | | | @1 324-326 |
|---|
| A21 | | | | @1 1996 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000043010170160 |
|---|
| A44 | | | | @0 0000 |
|---|
| A45 | | | | @0 31 ref. |
|---|
| A47 | 01 | 1 | | @0 96-0244904 |
|---|
| A60 | | | | @1 P @3 CC |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C02 | 01 | X | | @0 002B02U01 |
|---|
| C03 | 01 | X | FRE | @0 Fluoxétine @2 NK @2 FR @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Antidépresseur @5 02 |
|---|
| C03 | 02 | X | ENG | @0 Antidepressant agent @5 02 |
|---|
| C03 | 02 | X | SPA | @0 Antidepresor @5 02 |
|---|
| C03 | 03 | X | FRE | @0 Psychotrope @2 FX @5 03 |
|---|
| C03 | 03 | X | ENG | @0 Psychotropic @2 FX @5 03 |
|---|
| C03 | 03 | X | SPA | @0 Psicotropo @2 FX @5 03 |
|---|
| C03 | 04 | X | FRE | @0 Inhibiteur recapture @5 04 |
|---|
| C03 | 04 | X | ENG | @0 Reuptake inhibitor @5 04 |
|---|
| C03 | 04 | X | SPA | @0 Inhibidor recaptura @5 04 |
|---|
| C03 | 05 | X | FRE | @0 Sérotonine @2 NK @2 FR @5 05 |
|---|
| C03 | 05 | X | ENG | @0 Serotonin @2 NK @2 FR @5 05 |
|---|
| C03 | 05 | X | SPA | @0 Serotonina @2 NK @2 FR @5 05 |
|---|
| C03 | 06 | X | FRE | @0 Mouvement involontaire @5 07 |
|---|
| C03 | 06 | X | ENG | @0 Involuntary movement @5 07 |
|---|
| C03 | 06 | X | SPA | @0 Movimiento involuntario @5 07 |
|---|
| C03 | 07 | X | FRE | @0 Traitement @5 17 |
|---|
| C03 | 07 | X | ENG | @0 Treatment @5 17 |
|---|
| C03 | 07 | X | GER | @0 Aufbereiten @5 17 |
|---|
| C03 | 07 | X | SPA | @0 Tratamiento @5 17 |
|---|
| C03 | 08 | X | FRE | @0 Chimiothérapie @5 18 |
|---|
| C03 | 08 | X | ENG | @0 Chemotherapy @5 18 |
|---|
| C03 | 08 | X | SPA | @0 Quimioterapia @5 18 |
|---|
| C03 | 09 | X | FRE | @0 Toxicité @5 19 |
|---|
| C03 | 09 | X | ENG | @0 Toxicity @5 19 |
|---|
| C03 | 09 | X | GER | @0 Giftigkeit @5 19 |
|---|
| C03 | 09 | X | SPA | @0 Toxicidad @5 19 |
|---|
| C03 | 10 | X | FRE | @0 Homme @5 20 |
|---|
| C03 | 10 | X | ENG | @0 Human @5 20 |
|---|
| C03 | 10 | X | SPA | @0 Hombre @5 20 |
|---|
| C03 | 11 | X | FRE | @0 Etude cas @5 21 |
|---|
| C03 | 11 | X | ENG | @0 Case study @5 21 |
|---|
| C03 | 11 | X | SPA | @0 Estudio caso @5 21 |
|---|
| C07 | 01 | X | FRE | @0 Système nerveux pathologie @5 53 |
|---|
| C07 | 01 | X | ENG | @0 Nervous system diseases @5 53 |
|---|
| C07 | 01 | X | SPA | @0 Sistema nervioso patología @5 53 |
|---|
| C07 | 02 | X | FRE | @0 Trouble neurologique @5 54 |
|---|
| C07 | 02 | X | ENG | @0 Neurological disorder @5 54 |
|---|
| C07 | 02 | X | SPA | @0 Trastorno neurológico @5 54 |
|---|
| N21 | | | | @1 169 |
|---|
|
|---|
Format Inist (serveur)
| NO : | PASCAL 96-0244904 INIST |
|---|
| ET : | Complex movement disorders induced by fluoxetine |
|---|
| AU : | BHARUCHA (K. J.); SETHI (K. D.) |
|---|
| AF : | Department of Neurology, Medical College of Georgia/Augusta, Georgia/Etats-Unis (1 aut., 2 aut.) |
|---|
| DT : | Publication en série; Courte communication, note brève; Niveau analytique |
|---|
| SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 3; Pp. 324-326; Bibl. 31 ref. |
|---|
| LA : | Anglais |
|---|
| CC : | 002B02U01 |
|---|
| FD : | Fluoxétine; Antidépresseur; Psychotrope; Inhibiteur recapture; Sérotonine; Mouvement involontaire; Traitement; Chimiothérapie; Toxicité; Homme; Etude cas |
|---|
| FG : | Système nerveux pathologie; Trouble neurologique |
|---|
| ED : | Antidepressant agent; Psychotropic; Reuptake inhibitor; Serotonin; Involuntary movement; Treatment; Chemotherapy; Toxicity; Human; Case study |
|---|
| EG : | Nervous system diseases; Neurological disorder |
|---|
| GD : | Aufbereiten; Giftigkeit |
|---|
| SD : | Antidepresor; Psicotropo; Inhibidor recaptura; Serotonina; Movimiento involuntario; Tratamiento; Quimioterapia; Toxicidad; Hombre; Estudio caso |
|---|
| LO : | INIST-20953.354000043010170160 |
|---|
| ID : | 96-0244904 |
|---|
Links to Exploration step
Pascal:96-0244904
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Complex movement disorders induced by fluoxetine</title>
<author><name sortKey="Bharucha, K J" sort="Bharucha, K J" uniqKey="Bharucha K" first="K. J." last="Bharucha">K. J. Bharucha</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Medical College of Georgia</s1>
<s2>Augusta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><author><name sortKey="Sethi, K D" sort="Sethi, K D" uniqKey="Sethi K" first="K. D." last="Sethi">K. D. Sethi</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Medical College of Georgia</s1>
<s2>Augusta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">96-0244904</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0244904 INIST</idno>
<idno type="RBID">Pascal:96-0244904</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003388</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Complex movement disorders induced by fluoxetine</title>
<author><name sortKey="Bharucha, K J" sort="Bharucha, K J" uniqKey="Bharucha K" first="K. J." last="Bharucha">K. J. Bharucha</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Medical College of Georgia</s1>
<s2>Augusta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><author><name sortKey="Sethi, K D" sort="Sethi, K D" uniqKey="Sethi K" first="K. D." last="Sethi">K. D. Sethi</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Medical College of Georgia</s1>
<s2>Augusta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1996">1996</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antidepressant agent</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Human</term>
<term>Involuntary movement</term>
<term>Psychotropic</term>
<term>Reuptake inhibitor</term>
<term>Serotonin</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Fluoxétine</term>
<term>Antidépresseur</term>
<term>Psychotrope</term>
<term>Inhibiteur recapture</term>
<term>Sérotonine</term>
<term>Mouvement involontaire</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Toxicité</term>
<term>Homme</term>
<term>Etude cas</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Complex movement disorders induced by fluoxetine</s1>
</fA08><fA11 i1="01" i2="1"><s1>BHARUCHA (K. J.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>SETHI (K. D.)</s1>
</fA11><fA14 i1="01"><s1>Department of Neurology, Medical College of Georgia</s1>
<s2>Augusta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14><fA20><s1>324-326</s1>
</fA20><fA21><s1>1996</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000043010170160</s5>
</fA43><fA44><s0>0000</s0>
</fA44><fA45><s0>31 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>96-0244904</s0>
</fA47><fA60><s1>P</s1>
<s3>CC</s3>
</fA60><fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B02U01</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Fluoxétine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Antidépresseur</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Antidepressant agent</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Antidepresor</s0>
<s5>02</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Psychotrope</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Psychotropic</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Psicotropo</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Inhibiteur recapture</s0>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Reuptake inhibitor</s0>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Inhibidor recaptura</s0>
<s5>04</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Sérotonine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Serotonin</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Serotonina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>07</s5>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>07</s5>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>07</s5>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03><fC03 i1="07" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>18</s5>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>18</s5>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>18</s5>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>19</s5>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>19</s5>
</fC03><fC03 i1="09" i2="X" l="GER"><s0>Giftigkeit</s0>
<s5>19</s5>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>19</s5>
</fC03><fC03 i1="10" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03><fC03 i1="10" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03><fC03 i1="10" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03><fC03 i1="11" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>21</s5>
</fC03><fC03 i1="11" i2="X" l="ENG"><s0>Case study</s0>
<s5>21</s5>
</fC03><fC03 i1="11" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>21</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>53</s5>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>53</s5>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>53</s5>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>54</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>54</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>54</s5>
</fC07><fN21><s1>169</s1>
</fN21><server><NO>PASCAL 96-0244904 INIST</NO>
<ET>Complex movement disorders induced by fluoxetine</ET>
<AU>BHARUCHA (K. J.); SETHI (K. D.)</AU>
<AF>Department of Neurology, Medical College of Georgia/Augusta, Georgia/Etats-Unis (1 aut., 2 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 3; Pp. 324-326; Bibl. 31 ref.</SO>
<LA>Anglais</LA>
<CC>002B02U01</CC>
<FD>Fluoxétine; Antidépresseur; Psychotrope; Inhibiteur recapture; Sérotonine; Mouvement involontaire; Traitement; Chimiothérapie; Toxicité; Homme; Etude cas</FD>
<FG>Système nerveux pathologie; Trouble neurologique</FG>
<ED>Antidepressant agent; Psychotropic; Reuptake inhibitor; Serotonin; Involuntary movement; Treatment; Chemotherapy; Toxicity; Human; Case study</ED>
<EG>Nervous system diseases; Neurological disorder</EG>
<GD>Aufbereiten; Giftigkeit</GD>
<SD>Antidepresor; Psicotropo; Inhibidor recaptura; Serotonina; Movimiento involuntario; Tratamiento; Quimioterapia; Toxicidad; Hombre; Estudio caso</SD>
<LO>INIST-20953.354000043010170160</LO>
<ID>96-0244904</ID>
</server>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003388 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003388 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:96-0244904
|texte= Complex movement disorders induced by fluoxetine
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
